Home/Filings/4/0001213900-20-014428
4//SEC Filing

Kles Or 4

Accession 0001213900-20-014428

CIK 0001211805other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 5:56 PM ET

Size

17.5 KB

Accession

0001213900-20-014428

Insider Transaction Report

Form 4
Period: 2020-05-25
Kles Or
Chief Financial Officer
Transactions
  • Award

    Option to purchase Common Stock (right to buy)

    2020-05-25+4,00014,000 total
    Exercise: $1.04Exp: 2025-05-29Common Stock, $.001 par value per share (4,000 underlying)
  • Award

    Option to purchase Common Stock (right to buy)

    2020-05-25+10,00010,000 total
    Exercise: $1.04Exp: 2025-05-29Common Stock, $.001 par value per share (10,000 underlying)
  • Award

    Option to purchase Common Stock (right to buy)

    2020-05-25+5,6675,667 total
    Exercise: $1.04Exp: 2023-07-24Common Stock, $.001 par value per share (5,667 underlying)
  • Disposition to Issuer

    Option to purchase Common Stock (right to buy)

    2020-05-2510,0000 total
    Exercise: $11.40Exp: 2024-05-29Common Stock, $.001 par value per share (10,000 underlying)
  • Disposition to Issuer

    Option to purchase Common Stock (right to buy)

    2020-05-255,6670 total
    Exercise: $18.15Exp: 2022-07-24Common Stock, $.001 par value per share (5,667 underlying)
  • Disposition to Issuer

    Option to purchase Common Stock (right to buy)

    2020-05-254,0000 total
    Exercise: $11.40Exp: 2024-05-29Common Stock, $.001 par value per share (4,000 underlying)
Footnotes (4)
  • [F1]Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.
  • [F2]Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged.
  • [F3]Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged.
  • [F4]Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on May 1, 2020, one third of the total shares vests on May 1, 2021 and the remaining one third of the total shares vests on May 1, 2022.

Documents

1 file

Issuer

My Size, Inc.

CIK 0001211805

Entity typeother

Related Parties

1
  • filerCIK 0001686316

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:56 PM ET
Size
17.5 KB